BFA
ENZN

BlackRock Fund Advisors’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

BlackRock Fund Advisors’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,066,283
Closed -$1.1M – 3928
2014
Q1 		$1.1M Buy
1,066,283
+10,083
+1% +$10.4K ﹤0.01% 3189
2013
Q4 		$1.23M Sell
1,056,200
-514,762
-33% -$793K ﹤0.01% 3180
2013
Q3 		$2.64M Buy
1,570,962
+185,013
+13% +$342K ﹤0.01% 3077
2013
Q2 		$2.77M Buy
+1,385,949
New +$4.06M ﹤0.01% 3025

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock Fund Advisors's ENZN Position: Q2 2014 in Review

BlackRock Fund Advisors sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2014, closing a stake of 1,066,283 shares — an estimated $1.1M sold.

BlackRock Fund Advisors first reported a position in ENZN in Q2 2013 and held it in 4 quarters. The position peaked at $2.77M in Q2 2013. 67 funds tracked by Wall St. Rank hold ENZN as of Q2 2014.

  • BlackRock Fund Advisors reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • BlackRock Fund Advisors sold 1,066,283 ENZON PHARMACEUTICALS INC shares in Q2 2014, an estimated $1.1M.
  • BlackRock Fund Advisors first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 4 quarters.
  • BlackRock Fund Advisors's ENZON PHARMACEUTICALS INC position peaked at $2.77M in Q2 2013.
  • 67 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2014.

Based on BlackRock Fund Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.